articleCirculationFeb 24, 2003Closed access

Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease

Cincinnati Children's Hospital Medical Center · Boston Children's Hospital · +8 more institutions

Indexed incrossref

Abstract

Background— Low cardiac output syndrome (LCOS), affecting up to 25% of neonates and young children after cardiac surgery, contributes to postoperative morbidity and mortality. This study evaluated the efficacy and safety of prophylactic milrinone in pediatric patients at high risk for developing LCOS. Methods and Results— The study was a double-blind, placebo-controlled trial with 3 parallel groups (low dose, 25-μg/kg bolus over 60 minutes followed by a 0.25-μg/kg per min infusion for 35 hours; high dose, 75-μg/kg bolus followed by a 0.75-μg/kg per min infusion for 35 hours; or placebo). The composite end point of death or the development of LCOS was evaluated at 36 hours and up to 30 days after randomization.…

Citation impact

761
total citations
FWCI
19.18
Percentile
100%
References
16
Citations per year

Authors

12

Topics & keywords

Keywords
  • Milrinone
  • Medicine
  • Placebo
  • Randomization
  • Anesthesia
  • Bolus (digestion)
  • Heart disease
  • Cardiac surgery
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.